Acne treatments differ between dermatologists and pediatricians, study shows

Article

A study examined the difference in prescribing patterns between pediatricians and dermatologists when it came to acne treatments.

A study published in the Journal of Investigative Dermatology, investigated whether differences existed in how pediatricians and dermatologists prescribed acne treatments to patients.1

The study was a population-based, cross-sectional analysis using data from the National Ambulatory Medical Care Survey from 2002 to 2016 for pediatric patients ages 18 or younger.

There were 45.8 million outpatient acne visits for pediatric patients. With the data broken down, 54% of visits were conducted by dermatologists, 28% by pediatricians, and 18% by other providers. Compared to pediatricians, dermatologists treated older patients with a mean of 15.4 years versus 13.1 years old.

Dermatologists also saw a higher proportion of White patients (92.8% vs 79.7%), non-Hispanic patients (86.8% vs 76.9%), and patients with private insurance (83.1% vs 69.5%) compared to pediatricians.

The most frequently prescribed medication classes by both dermatologist and pediatricians included topical retinoids at 41% and topical combination therapies at 20.1%.

Compared to patients seen by dermatologists, patients seen by pediatricians were 71% less likely to receive topical retinoids, 48% less likely to receive topical antibiotics, and 53% less likely to receive oral antibiotics.1

Pediatricians prescribed topical retinoids, topical antibiotics, and oral antibiotics less frequently compared to dermatologists. According to the authors of the study, it is important to understand these differences in prescribing patterns for acne care and to identify potential educational gaps.

Reference:

1. Jones M, Pourali S, Kohn AH, et al. 240 Differences in Acne Therapy Prescribing Patterns Between Pediatricians and Dermatologists. Accessed: May 10, 2021. J Invest Dermatol. 2021;141(5):S43. doi:10.1016/j.jid.2021.02.262

This article was originally published on Dermatology Times®

Related Videos
Understanding combined oral contraceptives and breast cancer risk | Image Credit: health.ucdavis.edu
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
Enhancing cervical cancer management with dual stain | Image Credit: linkedin.com
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Understanding the impact of STIs on young adults | Image Credit: providers.ucsd.edu.
CDC estimates of maternal mortality found overestimated | Image Credit: rwjms.rutgers.edu.
Study unveils maternal mortality tracking trends | Image Credit: obhg.com
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit: hyperemesis.org
Unveiling gender disparities in medicine | Image Credit:  findcare.ahn.org.
Related Content
© 2024 MJH Life Sciences

All rights reserved.